About Enhancer
| Enhancer ID: | E_01_0691 |
| Species: | human |
| Position : | chr20:32355424-32357424   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Myeloid malignancies |
| Pubmed ID: | 30266822 |
| Enhancer experiment: | Histone extraction, histone western blot?Lentivirus infection?ChIP assay?ChIP-seq |
| Enhancer experiment description: | Thus, in addition to promoting myeloid malignancies, ASXL1 controls epigenetic reprogramming of osteoclasts to regulate bone resorption and mass. |
About Target gene
| Target gene : | ASXL1 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Thus, in addition to promoting myeloid malignancies, ASXL1 controls epigenetic reprogramming of osteoclasts to regulate bone resorption and mass. |
About TF
| TF name : | -- |
| TF experiment: | Histone extraction, histone western blot?Lentivirus infection?ChIP assay?ChIP-seq |
| TF experiment description: | Thus, in addition to promoting myeloid malignancies, ASXL1 controls epigenetic reprogramming of osteoclasts to regulate bone resorption and mass. |
About Function
| Enhancer function : | Thus, in addition to promoting myeloid malignancies, ASXL1 controls epigenetic reprogramming of osteoclasts to regulate bone resorption and mass. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Thus, in addition to promoting myeloid malignancies, ASXL1 controls epigenetic reprogramming of osteoclasts to regulate bone resorption and mass. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene